CareerPlan

Head of European Market Access – Oncology (Solid Tumors)

Zug, SwitzerlandFull-time2026-11-05 → 2026-11-19
Hybrid

Core

Drive pricing, reimbursement, health technology assessment, and patient access strategies for Summit's oncology portfolio across Europe.

Role type

Senior European Market Access Leader (Oncology)

Builds

Sustainable pricing and reimbursement outcomes for innovative oncology therapies in Europe

Domain

Biopharmaceuticals / Oncology / European Healthcare Systems

Required skills

European market access strategy, solid tumor oncology expertise (NSCLC, CRC, bladder/urothelial), HTA framework knowledge (AMNOG, NICE, HAS, AIFA), pricing and reimbursement strategy, health economic modeling, stakeholder management with payers and HTA bodies, clinical trial design input, evidence generation strategy

Preferred skills

Experience in EU5 markets, knowledge of EU HTA Regulation, managed entry agreements, outcomes-based contracts, real-world evidence strategies

Technologies

AMNOG, G-BA, IQWiG, HAS, NICE, AIFA, CEPS, SMC, GKV-Spitzenverband, Transparency Committee, SMR/ASMR, EU HTA Regulation

Responsibilities

Develop and execute integrated European market access strategy; Lead access planning across EU5 and additional strategic markets; Translate global pricing objectives into country-specific strategies; Lead development of pricing, reimbursement, and HTA strategies; Partner with Clinical Development and Medical Affairs to integrate payer requirements into trial design; Guide European evidence generation to strengthen value propositions

Seniority

Senior, strategic leadership with hands-on execution